Evidence map›Paper›PMID 34610330›Full record

ArticleDevelopmental cell2021

Neuroblastoma differentiation in vivo excludes cranial tumors.

Randall W Treffy, Sriivatsan G Rajan, Xinghang Jiang, Lynne M Nacke, Usama A Malkana, L A Naiche, Dani E Bergey, Dianicha Santana, Vinodh Rajagopalan, Jan K Kitajewski and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Randall W TreffyDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Sriivatsan G RajanDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Xinghang JiangDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Lynne M NackeDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Usama A MalkanaDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
L A NaicheDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612, USA.
Dani E BergeyDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Dianicha SantanaDepartment of Pharmacology, University of Illinois at Chicago, Chicago, IL 60612, USA.
Vinodh RajagopalanDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
Jan K KitajewskiDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612, USA.
John P O'BryanDepartment of Pharmacology, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA; Jesse Brown VA Medical Center, Chicago, IL 60612, USA; Ralph H. Johnson VA Medical Center, Charleston, SC 29401, USA.
Ankur SaxenaDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA. Electronic address: saxenaa@uic.edu.
University of Illinois Chicago · USMedical University of South Carolina · USMUSC Hollings Cancer Center · US

Funding

The role of SMAD1 and SATB2 in colon patterningP20GM130457 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Hailong Zhang · 2020 to 2026
$18.7M
Notch in Angiogenesis and Vascular BiologyR01HL112626 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Jan K. Kitajewski · 2012 to 2026
$6.3M
NOTCH FUNCTION IN VASCULAR BIOLOGY AND ANGIOGENESISR01HL062454 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KITAJEWSKI, JAN K. · 1999 to 2010
$3.4M
Intramural VA VA999999NHLBI NIH HHS R01 HL062454NHLBI NIH HHS R01 HL112626
6 · The paper itself

Abstract

Neuroblastoma (NB), the most common cancer in the first year of life, presents almost exclusively in the trunk. To understand why an early-onset cancer would have such a specific localization, we xenotransplanted human NB cells into discrete neural crest (NC) streams in zebrafish embryos. Here, we demonstrate that human NB cells remain in an undifferentiated, tumorigenic state when comigrating posteriorly with NC cells but, upon comigration into the head, differentiate into neurons and exhibit decreased survival. Furthermore, we demonstrate that this in vivo differentiation requires retinoic acid and brain-derived neurotrophic factor signaling from the microenvironment, as well as cell-autonomous intersectin-1-dependent phosphoinositide 3-kinase-mediated signaling, likely via Akt kinase activation. Our findings suggest a microenvironment-driven explanation for NB's trunk-biased localization and highlight the potential for induced differentiation to promote NB resolution in vivo.

Indexed as

AnimalsBrain-Derived Neurotrophic FactorCell DifferentiationCell Line, TumorCell MovementFemaleHumansMaleMiceNeural CrestNeuroblastomaNeuronsSignal TransductionTransplantation, HeterologousTretinoinTumor MicroenvironmentBrain-Derived Neurotrophic FactorTretinoindifferentiating microenvironmentlive imagingneuroblastomaneuronal differentiationpediatric cancer

Identifiers

PMID34610330
PMCPMC10796072
OpenAlexW3202575604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.